Clinical Trial Update: Naltrexone in Borderline Personality Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial of naltrexone for Borderline Personality Disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Borderline Personality Disorder | Phase 3 | Status: TERMINATED